These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24060178)

  • 61. A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma.
    Ramos L; Truong S; Zhai B; Joshi J; Ghaidi F; Lizardo MM; Shyp T; Kung SHY; Rezakhanlou AM; Oo HZ; Adomat H; Le Bihan S; Collins C; Bacha J; Brown D; Langlands J; Shen W; Lallous N; Sorensen PH; Daugaard M
    Clin Cancer Res; 2023 Sep; 29(17):3541-3553. PubMed ID: 37279093
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Histone deacetylase inhibitor: antineoplastic agent and radiation modulator.
    Konsoula Z; Velena A; Lee R; Dritschilo A; Jung M
    Adv Exp Med Biol; 2011; 720():171-9. PubMed ID: 21901627
    [TBL] [Abstract][Full Text] [Related]  

  • 63. DNA Repair Inhibitors Potentiate Fractionated Radiotherapy More Than Single-Dose Radiotherapy in Breast Cancer Cells.
    Wong WK; Guerra Liberal FDC; McMahon SJ
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954456
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Albendazole sensitizes cancer cells to ionizing radiation.
    Patel K; Doudican NA; Schiff PB; Orlow SJ
    Radiat Oncol; 2011 Nov; 6():160. PubMed ID: 22094106
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Radiosensitization of cervical cancer cells with epigenetic drugs hydralazine and valproate.
    Mani E; Medina LA; Isaac-Olivé K; Dueñas-González A
    Eur J Gynaecol Oncol; 2014; 35(2):140-2. PubMed ID: 24772915
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The epigenetic modifier, valproic acid, enhances radiation sensitivity.
    Karagiannis TC; Kn H; El-Osta A
    Epigenetics; 2006; 1(3):131-7. PubMed ID: 17965607
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Radiosensitizing potential of epigenetic anticancer drugs.
    De Schutter H; Nuyts S
    Anticancer Agents Med Chem; 2009 Jan; 9(1):99-108. PubMed ID: 19149485
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HDAC inhibitor confers radiosensitivity to prostate stem-like cells.
    Frame FM; Pellacani D; Collins AT; Simms MS; Mann VM; Jones GD; Meuth M; Bristow RG; Maitland NJ
    Br J Cancer; 2013 Dec; 109(12):3023-33. PubMed ID: 24220693
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Radiosensitization
    Groselj B; Ruan JL; Scott H; Gorrill J; Nicholson J; Kelly J; Anbalagan S; Thompson J; Stratford MRL; Jevons SJ; Hammond EM; Scudamore CL; Kerr M; Kiltie AE
    Mol Cancer Ther; 2018 Feb; 17(2):381-392. PubMed ID: 28839000
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Simvastatin treatment varies the radiation response of human breast cells in 2D or 3D culture.
    Manda K; Juerß D; Fischer P; Schröder A; Koenen A; Hildebrandt G
    Invest New Drugs; 2021 Jun; 39(3):658-669. PubMed ID: 33313978
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Examination of Gossypol-Pluronic Micelles as Potential Radiosensitizers.
    Tomoda K; Chiang C; Kozak KR; Kwon GS
    AAPS J; 2015 Nov; 17(6):1369-75. PubMed ID: 26246329
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CX-5461 induces radiosensitization through modification of the DNA damage response and not inhibition of RNA polymerase I.
    Lehman SL; Schwartz KR; Maheshwari S; Camphausen K; Tofilon PJ
    Sci Rep; 2022 Mar; 12(1):4059. PubMed ID: 35260696
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential killing and radio-modifying effects of iodoacetate in mammalian normal and cancer cells.
    Yadav U; Anjaria KB; Nairy R; Shirsath KB; Desai UN; Chaurasia RK; Bhat NN; Sapra BK
    Radiat Environ Biophys; 2017 Aug; 56(3):227-239. PubMed ID: 28612110
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Radioprotection by the histone deacetylase inhibitor phenylbutyrate.
    Miller AC; Cohen S; Stewart M; Rivas R; Lison P
    Radiat Environ Biophys; 2011 Nov; 50(4):585-96. PubMed ID: 21892632
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity.
    Dohmen AJC; Qiao X; Duursma A; Wijdeven RH; Lieftink C; Hageman F; Morris B; Halonen P; Vens C; van den Brekel MWM; Ovaa H; Neefjes J; Zuur CL
    Oncotarget; 2017 Sep; 8(43):73925-73937. PubMed ID: 29088757
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synergistic Radiosensitization by Gold Nanoparticles and the Histone Deacetylase Inhibitor SAHA in 2D and 3D Cancer Cell Cultures.
    Igaz N; Szőke K; Kovács D; Buhala A; Varga Z; Bélteky P; Rázga Z; Tiszlavicz L; Vizler C; Hideghéty K; Kónya Z; Kiricsi M
    Nanomaterials (Basel); 2020 Jan; 10(1):. PubMed ID: 31963267
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Radiosensitization by the Selective Pan-FGFR Inhibitor LY2874455.
    Darwis NDM; Horigome E; Li S; Adachi A; Oike T; Shibata A; Hirota Y; Ohno T
    Cells; 2022 May; 11(11):. PubMed ID: 35681425
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cell-line dependent effects of hypoxia prior to irradiation in squamous cell carcinoma lines.
    Hauth F; Toulany M; Zips D; Menegakis A
    Clin Transl Radiat Oncol; 2017 Aug; 5():12-19. PubMed ID: 29594212
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fractionation-Dependent Radiosensitization by Molecular Targeting of Nek1.
    Freund I; Hehlgans S; Martin D; Ensminger M; Fokas E; Rödel C; Löbrich M; Rödel F
    Cells; 2020 May; 9(5):. PubMed ID: 32429458
    [TBL] [Abstract][Full Text] [Related]  

  • 80. UNG2 deacetylation confers cancer cell resistance to hydrogen peroxide-induced cytotoxicity.
    Bao Y; Tong L; Song B; Liu G; Zhu Q; Lu X; Zhang J; Lu YF; Wen H; Tian Y; Sun Y; Zhu WG
    Free Radic Biol Med; 2020 Nov; 160():403-417. PubMed ID: 32649985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.